Warnings: You should seek medical advice regarding medications and use only as directed by a healthcare professional
The diagnostic process typically involves: Clinical history taking, focusing on symptoms (fatigue, neurological changes, dietary habits) Physical examination for signs of anaemia or neurological impairment Blood tests including full blood count, serum B12, and often folate levels Additional investigations such as intrinsic factor antibodies or parietal cell antibodies if pernicious anaemia is suspected For borderline results, additional tests like holotranscobalamin (active B12) may be considered NICE guidance recommends that treatment should commence based on clinical presentation if neurological symptoms are present, without waiting for laboratory confirmation, as delays can result in irreversible nerve damage
Fagelman, Delita and Staff
It activates three key hormone receptors involved in metabolic health: Reduces appetite, improves insulin sensitivity Supports insulin release and metabolic balance Increases energy expenditure, promotes fat breakdown This triple-agonist approach is designed to produce greater and faster weight loss than all other therapies
Digestive Disorders: Individuals with conditions such as Crohns disease or celiac disease may experience impaired absorption of B12 in the intestines
Research shows that the peptide reduces fat mass without corresponding decreases in lean tissue, indicating muscle preservation during fat loss